Careers  |  Sign In  |  Register  |   Twitter

Latest in Pharmacists

Reuters Health • The Doctor's Channel Daily Newscast

Fenofibric acid plus a statin seen safe, effective in women with mixed dyslipidemia

NEW YORK (Reuters Health) – The combination of fibrate and statin therapy is a safe and efficacious treatment option for women with multiple lipid abnormalities, a multicenter team reports in the January 20 online issue of the American Journal of Cardiology. That conclusion comes from a post hoc analysis...

Reuters Health • The Doctor's Channel Daily Newscast

Ivabradine safe, effective in CAD patients with reduced ejection fraction

NEW YORK (Reuters Health) – The selective sinoatrial I-f current inhibitor ivabradine lowers heart rate in patients with stable coronary artery disease and impaired left ventricular systolic function without causing an increase in rhythm disturbances, according to a study reported in the American Journal...

Reuters Health • The Doctor's Channel Daily Newscast

Genetic tables for warfarin dosing not as good as pharmacogenetic algorithms

NEW YORK (Reuters Health) – Warfarin dosing based on genotype-stratified tables is more accurate than empiric dosing, but not as good as estimates derived from formal pharmacogenetic algorithms, investigators report in the Journal of the American College of Cardiology for February 1. Dr. Stephen E. Kimmel,...